Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Derya Selim Batur"'
Autor:
Anıl Tombak, Funda Pepedil Tanrıkulu, Salih Sertaç Durusoy, Hüseyin Derya Dinçyürek, Emin Kaya, Elif Gülsüm Ümit, İrfan Yavaşoğlu, Özgür Mehtap, Burak Deveci, Mehmet Ali Özcan, Hatice Terzi, Müfide Okay, Nilgün Sayınalp, Mehmet Yılmaz, Vahap Okan, Alperen Kızıklı, Ömer Özcan, Güven Çetin, Sinan Demircioğlu, İsmet Aydoğdu, Güray Saydam, Eren Arslan Davulcu, Gül İlhan, Mehmet Ali Uçar, Gülsüm Özet, Seval Akpınar, Burhan Turgut, İlhami Berber, Erdal Kurtoğlu, Mehmet Sönmez, Derya Selim Batur, Rahşan Yıldırım, Vildan Özkocaman, Ahmet Kürşad Güneş, Birsen Sahip, Şehmus Ertop, Olga Meltem Akay, Abdülkadir Baştürk, Mehmet Hilmi Doğu, Aydan Akdeniz, Ali Ünal, Ahmet Seyhanlı, Emel Gürkan, Demet Çekdemir, Burhan Ferhanoğlu
Publikováno v:
Turkish Journal of Hematology, Vol 38, Iss 4, Pp 273-285 (2021)
Objective: This study aimed to retrospectively evaluate the efficacy, safety, and survival outcome of single-agent ibrutinib therapy in chronic lymphocytic leukemia patients. Materials and Methods: A total of 136 patients (mean age +- standard deviat
Externí odkaz:
https://doaj.org/article/506b9a34c2d64dd5beb096f766347808
Autor:
Sehmus Ertop, Alperen Kizikli, Rahsan Yildirim, Huseyin Derya Dincyurek, Nilgun Sayinalp, Sinan Demircioğlu, Güray Saydam, Ismet Aydogdu, Abdulkadir Basturk, Erdal Kurtoğlu, Ahmet Seyhanli, Olga Meltem Akay, Hatice Terzi, Burak Deveci, Omer Ozcan, Eren Arslan Davulcu, Güven Çetin, Ali Ünal, Emel Gürkan, Vahap Okan, Elif Gülsüm Ümit, Aydan Akdeniz, Burhan Turgut, Vildan Özkocamaz, Anil Tombak, Derya Selim Batur, Mehmet Sönmez, Ilhami Berber, Burhan Ferhanoglu, Birsen Sahip, Mehmet Ali Ucar, Ahmet Kursad Gunes, Mehmet Yilmaz, Mehmet Ali Özcan, Mehmet Hilmi Dogu, Gül İlhan, Gülsüm Özet, Seval Akpinar, Funda Pepedil Tanrikulu, Demet Çekdemir, Emin Kaya, Özgür Mehtap, Mufide Okay, Irfan Yavasoglu, Salih Sertac Durusoy
Publikováno v:
Turkish Journal of Hematology
Objective: This study aimed to retrospectively evaluate the efficacy, safety, and survival outcome of single-agent ibrutinib therapy in chronic lymphocytic leukemia patients. Materials and Methods: A total of 136 patients (mean age +/- standard devia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5976c7adba53564e1d4f94514645acfd
https://hdl.handle.net/20.500.11776/8832
https://hdl.handle.net/20.500.11776/8832
Publikováno v:
LLM Dergi. 1:43-48
Publikováno v:
Chemotherapy. 63(4)
Background: Although cure rates in pediatric acute lymphoblastic leukemia (ALL) are quite high with combined chemotherapy regimens, complete response (CR) and long-term survival rates in adults are 80–90 and 30–40%, respectively. Currently, combi
Autor:
Salih Sertac Durusoy, Anil Tombak, Alperen Kizikli, Mehmet Sönmez, Mehmet Ali Özcan, Erdal Kurtoğlu, Mehmet Hilmi Dogu, Ahmet Seyhanli, Ali Ünal, Emel Gürkan, Rahsan Yildirim, Vahap Okan, Nilgun Sayinalp, Seval Akpinar, Burhan Turgut, Sehmus Ertop, Güray Saydam, Mehmet Ali Ucar, Burak Deveci, Güven Çetin, Gül İlhan, Omer Ozcan, Eren Arslan Davulcu, Özgür Mehtap, Mehmet Yilmaz, Ilhami Berber, Elif Gülsüm Ümit, Abdulkadir Basturk, Burhan Ferhanoglu, Birsen Sahip, Sinan Demircioğlu, Emin Kaya, Ismet Aydogdu, Mufide Okay, Irfan Yavasoglu, Meltem Olga Akay, Derya Selim Batur, Ahmet Kursat Gunes, Hatice Terzi, Aydan Akdeniz, Vildan Ozkocaman, Gülsüm Özet, Funda Pepedil Tanrikulu
Publikováno v:
Blood. 134:5476-5476
61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) -- DEC 07-10, 2019 -- Orlando, FL
BERBER, Ilhami/0000-0003-3312-8476
WOS:000577164606194
[No Abstract Available]
Amer Soc Hematol
BERBER, Ilhami/0000-0003-3312-8476
WOS:000577164606194
[No Abstract Available]
Amer Soc Hematol